Agents that bind to and inhibit human cytochrome P450 2C19
WO2005024043A2
Methods for identifying, diagnosing, and predicting survival of lymphomas
WO2005010034A1
Soluble fragments of the sars-cov spike glycoprotein
KR20050004131A
A chimeric clone of HIV-1 subtype B from Korean and method for preparation thereof
KR20050004130A
A nucleotide sequence of HIV-1 subtype B genomic DNA from Korean, a molecular clone comprising the nucleotide sequence and a method for preparation thereof
AU2003304215A1
Methods and compositions for selectively enriching microbes
AU2003294248A1
Smallpox vaccine regimen
US2005081608A1
System and method for the analysis of atomic force microscopy data
KR20050007102A
Protein inhibiting the aggregation of βamyloid peptide
AU2003301841A8
Immunotherapy regimens in hiv-infected patients
WO03077838A2
Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens
AU1130902A
Method to fabricate continuous lengths of helical coil shaped memory wire
KR20030021933A
Reporter gene-containing plasmid which is convertible to T-vector and the preparation method thereof
US6908738B2
Agents that bind to and inhibit human cytochrome P450 2C19
US7005258B1
Cdc25 genes, encoded products and uses thereof
US2002019594A1
Laparoscopic SAC holder assembly
KR20000031104A
Preparation method of protective antigen using transformed bacillus with recombinant vector introduced protective antigen
MXPA04001462A
Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias.
WO9729757A1
Rnase l activators and antisense oligonucleotides effective to treat rsv infections
